DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug voruciclib tested in Hard-to-Treat blood cancers
Disease control TerminatedThis early-phase study tested a new drug called voruciclib, alone or combined with another drug (venetoclax), in adults with certain blood cancers (like lymphoma or leukemia) that had returned or stopped responding to standard treatments. The main goal was to check safety and fin…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: MEI Pharma, Inc. • Aim: Disease control
Last updated May 26, 2026 05:58 UTC
-
New Dual-Targeting CAR t therapy shows promise in early lymphoma trial
Disease control TerminatedThis early-phase study tested a new treatment called bbT369 for people with B cell non-Hodgkin's lymphoma that came back or didn't respond to standard therapy. The treatment uses a patient's own immune cells, modified to target two markers on cancer cells, plus a gene edit to imp…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:55 UTC
-
New antibody drug GEN3014 tested in blood cancer patients – early results show promise
Disease control TerminatedThis study tested a new drug called GEN3014 in people with blood cancers like multiple myeloma, lymphoma, and leukemia that had returned or stopped responding to treatment. The main goal was to check the drug's safety and find the best dose. About 130 people took part, but the st…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 26, 2026 05:45 UTC